EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy

Author：              

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.2, 2011-01, pp. : 383-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early oncology clinical trial design in the era of molecular-targeted agents

By Brunetto Andre T   Kristeleit Rebecca S   de Bono Johann S  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1339-1352

Future Medicine

Access to resources Recommend Favorite

Effect of hydrothorax EGFR gene mutation and EGFRTKI targeted therapy on advanced nonsmall cell lung cancer patients

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1413-1417

Spandidos Publications

Access to resources Recommend Favorite

Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines

By                  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1805-1812

Spandidos Publications

Access to resources Recommend Favorite

Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer (Review)

By                  

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 3-8

Spandidos Publications

Access to resources Recommend Favorite

Structural analysis of the EGFR TK domain and potential implications for EGFR targeted therapy

By Nie Weiwei   Tang Lin   Zhang Haiyang   Shao Jiaqing   Wang Yucai   Chen Longbang   Li Donghai   Guan Xiaoxiang  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-06 ,pp. : 1763-1769

Spandidos Publications

Access to resources Recommend Favorite